Eventide Asset Management’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
Other funds holding MGNX
BG
HRCM
WA
GC
Eventide Asset Management's MGNX Position: Q3 2019 in Review
Eventide Asset Management sold out of MacroGenics (MGNX) in Q3 2019, closing a stake of 485,000 shares — an estimated $8.23M sold.
Eventide Asset Management first reported a position in MGNX in Q4 2013 and held it in 22 quarters. The position peaked at $23.6M in Q2 2015. 127 funds tracked by Wall St. Rank hold MGNX as of Q3 2019.
- Eventide Asset Management reported no remaining MacroGenics position as of Q3 2019 after selling out during the quarter.
- Eventide Asset Management sold 485,000 MacroGenics shares in Q3 2019, an estimated $8.23M.
- Eventide Asset Management first reported a position in MacroGenics in Q4 2013 and held it in 22 quarters.
- Eventide Asset Management's MacroGenics position peaked at $23.6M in Q2 2015.
- 127 funds tracked by Wall St. Rank held MacroGenics as of Q3 2019.
Based on Eventide Asset Management's 13F filing for Q3 2019, filed 21 Nov 2019.